Pathogenesis of endometriosis: natural immunity dysfunction or autoimmune disease?

被引:311
作者
Matarese, G
De Placido, G
Nikas, Y
Alviggi, C
机构
[1] Univ Naples Federico II, CNR, IEOS, Grp Immunoendocrinol, I-80131 Naples, Italy
[2] Univ Naples Federico II, Dipartimento Biol & Patol Cellulare & Mol, Cattedra Immunol, I-80131 Naples, Italy
[3] Univ Naples Federico II, Dipartimento Sci Ostetr Ginecol Urol & Med Riprod, I-80131 Naples, Italy
[4] Aretaieio Univ Hosp, Dept Obstet & Gynecol 2, Athens, Greece
关键词
D O I
10.1016/S1471-4914(03)00051-0
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
Endometriosis is a chronic inflammatory disease, characterized by implantation and growth of endometrial tissue outside the uterine cavity. This disabling condition is considered one of the most frequent diseases in gynecology, affecting 15-20% of women in their reproductive life. Pelvic endometriosis, the most common form of the disease, is associated with increased secretion of pro-inflammatory cytokines, neoangiogenesis, intrinsic anomalies of the refluxed endometrium and impaired function of cell-mediated natural immunity. Recently, endometriosis has also been considered to be an autoimmune disease, owing to the presence of autoantibodies, the association with other autoimmune diseases and recurrent immune-mediated abortion. These findings are in apparent contradiction with the reduced cell-mediated natural immunity observed during the disease. In this review, we focus on the multiple processes underlying the complex pathogenesis of endometriosis, with particular emphasis on the role played by the immune system with the induction of autoimmunity.
引用
收藏
页码:223 / 228
页数:6
相关论文
共 54 条
[1]
Estradiol and interleukin-1β exert a synergistic stimulatory effect on the expression of the chemokine regulated upon activation, normal T cell expressed, and secreted in endometriotic cells [J].
Akoum, A ;
Lemay, A ;
Maheux, R .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (12) :5785-5792
[2]
BADAWY SZA, 1990, FERTIL STERIL, V53, P930
[4]
Carbone E, 1999, EUR J IMMUNOL, V29, P4022, DOI 10.1002/(SICI)1521-4141(199912)29:12<4022::AID-IMMU4022>3.3.CO
[5]
2-F
[6]
Matrix metalloproteinase-2, membranous type 1 matrix metalloproteinase, and tissue inhibitor of metalloproteinase-2 expression in ectopic and eutopic endometrium [J].
Chung, HW ;
Lee, JY ;
Moon, HS ;
Hur, SE ;
Park, MH ;
Wen, Y ;
Polan, ML .
FERTILITY AND STERILITY, 2002, 78 (04) :787-795
[7]
Hyperprolactinemia and luteal insufficiency in infertile patients with mild and minimal endometriosis [J].
Cunha, JSL ;
Gross, IL ;
Lemos, NA ;
Brandelli, A ;
Castillos, M ;
Passos, EP .
HORMONE AND METABOLIC RESEARCH, 2001, 33 (04) :216-220
[8]
Serum concentrations of soluble human leukocyte class I antigens and of the soluble intercellular adhesion molecule-1 in endometriosis: relationship with stage and non-pigmented peritoneal lesions [J].
De Placido, G ;
Alviggi, C ;
Di Palma, G ;
Carravetta, C ;
Matarese, G ;
Landino, G ;
Racioppi, L .
HUMAN REPRODUCTION, 1998, 13 (11) :3206-3210
[9]
DEFICIENT CELLULAR-IMMUNITY IN ENDOMETRIOSIS [J].
DMOWSKI, WP ;
STEELE, RW ;
BAKER, GF .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1981, 141 (04) :377-383
[10]
Vascular endothelial growth factor (VEGF) in endometriosis [J].
Donnez, J ;
Smoes, P ;
Gillerot, S ;
Casanas-Roux, F ;
Nisolle, M .
HUMAN REPRODUCTION, 1998, 13 (06) :1686-1690